2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH
The present invention provides triazolone compounds compounds of general formula (I) : in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said c...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
03.05.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides triazolone compounds compounds of general formula (I) : in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
La présente invention concerne des composés triazolone de formule générale (I) : dans laquelle R1, R2, R3, R4 et R5 sont tels que définis dans la description. L'invention concerne également des procédés de préparation desdits composés, des composés intermédiaires utiles pour préparer lesdits composés, des compositions et combinaisons pharmaceutiques comprenant lesdits composés et l'utilisation desdits composés pour fabriquer des compositions pharmaceutiques pour le traitement ou la prophylaxie de maladies, en particulier de maladies hyperprolifératives, en monothérapie ou en association avec d'autres principes actifs. |
---|---|
Bibliography: | Application Number: CA20173041643 |